Funding
Turn ideas into impact
Show Me
Due: December 23, 2027
Catalyze: Product Definition Medical Device Prototype Optimization (R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-020
Due: December 23, 2027
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products – Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-017
Due: December 23, 2027
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 – Clinical Trials Not Allowed)
US $350,000
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-016
Due: January 4, 2028
DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH
Type
Cooperative Agreement
Source
Federal
Opp Number
W911NF-23-S-0003
Due: January 6, 2028
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAS-25-205
Due: January 7, 2028
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-319
Due: January 7, 2028
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PA-25-306
Due: January 7, 2028
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-027
Due: January 7, 2028
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-206
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?